BPMC
Price
$81.68
Change
-$5.43 (-6.23%)
Updated
Apr 4 closing price
Capitalization
5.22B
24 days until earnings call
OXBDF
Price
$3.71
Change
-$0.17 (-4.38%)
Updated
Apr 2 closing price
Capitalization
374.71M
Ad is loading...

BPMC vs OXBDF

Header iconBPMC vs OXBDF Comparison
Open Charts BPMC vs OXBDFBanner chart's image
Blueprint Medicines
Price$81.68
Change-$5.43 (-6.23%)
Volume$1.49M
Capitalization5.22B
Oxford Biomedica
Price$3.71
Change-$0.17 (-4.38%)
Volume$15K
Capitalization374.71M
BPMC vs OXBDF Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. OXBDF commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a StrongBuy and OXBDF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (BPMC: $81.68 vs. OXBDF: $3.71)
Brand notoriety: BPMC and OXBDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 141% vs. OXBDF: 253%
Market capitalization -- BPMC: $5.22B vs. OXBDF: $374.71M
BPMC [@Biotechnology] is valued at $5.22B. OXBDF’s [@Biotechnology] market capitalization is $374.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileOXBDF’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • OXBDF’s FA Score: 0 green, 5 red.
According to our system of comparison, BPMC is a better buy in the long-term than OXBDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 3 TA indicator(s) are bullish.

  • BPMC’s TA Score: 3 bullish, 5 bearish.

Price Growth

BPMC (@Biotechnology) experienced а -7.94% price change this week, while OXBDF (@Biotechnology) price change was -4.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.22B) has a higher market cap than OXBDF($375M). BPMC YTD gains are higher at: -6.352 vs. OXBDF (-31.233).
BPMCOXBDFBPMC / OXBDF
Capitalization5.22B375M1,392%
EBITDA19.2MN/A-
Gain YTD-6.352-31.23320%
P/E RatioN/AN/A-
Revenue509MN/A-
Total Cash615MN/A-
Total Debt469MN/A-
FUNDAMENTALS RATINGS
BPMC vs OXBDF: Fundamental Ratings
BPMC
OXBDF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
7360
P/E GROWTH RATING
1..100
4697
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OXBDF's Valuation (71) in the null industry is in the same range as BPMC (80) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (66) in the Biotechnology industry is somewhat better than the same rating for OXBDF (100) in the null industry. This means that BPMC’s stock grew somewhat faster than OXBDF’s over the last 12 months.

OXBDF's SMR Rating (92) in the null industry is in the same range as BPMC (94) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to BPMC’s over the last 12 months.

OXBDF's Price Growth Rating (60) in the null industry is in the same range as BPMC (73) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's P/E Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for OXBDF (97) in the null industry. This means that BPMC’s stock grew somewhat faster than OXBDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMC
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 15 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITRG1.16N/A
N/A
Integra Resources Corp
MNMD5.43-0.12
-2.16%
Mind Medicine (MindMed)
AAON74.20-3.28
-4.23%
AAON
LIN437.96-29.26
-6.26%
Linde plc
ENVA85.91-6.25
-6.78%
Enova International

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with ORIC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then ORIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-6.23%
ORIC - BPMC
44%
Loosely correlated
-7.22%
ARWR - BPMC
42%
Loosely correlated
-11.44%
DNLI - BPMC
41%
Loosely correlated
-7.90%
TECH - BPMC
41%
Loosely correlated
-5.72%
AXON - BPMC
41%
Loosely correlated
-7.89%
More

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and IMMP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and IMMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
IMMP - OXBDF
23%
Poorly correlated
-6.83%
BPMC - OXBDF
21%
Poorly correlated
-6.23%
BDTX - OXBDF
21%
Poorly correlated
-7.28%
ATNM - OXBDF
21%
Poorly correlated
-7.19%
UBX - OXBDF
20%
Poorly correlated
N/A
More